Pharmacogenetics of aspirin resistance: a comprehensive systematic review.

British Journal of Clinical Pharmacology
Timothy GoodmanPankaj Sharma

Abstract

The aim was to perform a systematic review of all candidate gene association studies in aspirin resistance. Electronic databases were searched up until 1 December 2007 for all studies investigating any candidate gene for aspirin resistance in humans. Aspirin resistance was required to have been measured by a standardized laboratory technique to be included in the analysis. Within 31 studies, 50 polymorphisms in 11 genes were investigated in 2834 subjects. The PlA1/A2 polymorphism in the GPIIIa platelet receptor was the most frequently investigated, with 19 studies in 1389 subjects. The PlA1/A2 variant was significantly associated with aspirin resistance when measured in healthy subjects [odds ratio (OR) 2.36, 95% confidence interval (CI) 1.24, 4.49; P = 0.009]. Combining genetic data from all studies (comprising both healthy subjects and those with cardiovascular disease) reduced the observed effect size (OR 1.14, 95% CI 0.84, 1.54; P = 0.40). Moreover, the observed effect of PlA1/A2 genotype varied depending on the methodology used for determining aspirin sensitivity/resistance. No significant association was found with aspirin resistance in four other investigated polymorphisms in the COX-1, GPla, P2Y1 or P2Y12 genes. Our dat...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Jun 27, 1998·Lancet·G E CookeP J Goldschmidt-Clermont
Apr 9, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·D FengG H Tofler
Jul 27, 2001·The American Journal of Cardiology·P A GumE J Topol
Aug 16, 2002·American Journal of Epidemiology·Julian LittleClarice Weinberg
Jan 25, 2003·Clinical Pharmacology and Therapeutics·Marc K HalushkaPerry V Halushka
Feb 5, 2004·American Heart Journal·Gad CotterAbraham Kornberg
Sep 25, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Marco Cattaneo
Dec 18, 2004·Stroke; a Journal of Cerebral Circulation·Rocio Gonzalez-ConejeroVincente Vicente
Mar 11, 2005·The American Journal of Cardiology·Brian K JeffersonEric J Topol
Apr 21, 2005·The Annals of Pharmacotherapy·Elod PappBela Melegh
Sep 10, 2005·Journal of Thrombosis and Haemostasis : JTH·A O MareeD J Fitzgerald
Jan 20, 2006·Journal of Thrombosis and Haemostasis : JTH·C P M HaywardUNKNOWN Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis
Feb 7, 2006·Journal of the American College of Cardiology·Glen E CookePascal J Goldschmidt-Clermont
Feb 21, 2006·Lancet·Graeme J Hankey, John W Eikelboom
Apr 26, 2006·Journal of Thrombosis and Haemostasis : JTH·P FontanaP de Moerloose
Nov 14, 2006·The American Journal of Cardiology·Alan D MichelsonMark I Furman
Mar 30, 2007·International Journal of Clinical Practice·Timothy GoodmanAlbert Ferro

❮ Previous
Next ❯

Citations

Feb 26, 2013·European Journal of Clinical Pharmacology·Eugenia Yiannakopoulou
Jul 6, 2012·Journal of Thrombosis and Thrombolysis·Vandana SharmaAnjana Munshi
Jun 20, 2013·Current Atherosclerosis Reports·Steve Bevan, Hugh S Markus
May 13, 2009·Current Treatment Options in Cardiovascular Medicine·Larisa H Cavallari, Kathryn M Momary
Apr 13, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Vincent Lai Ming Yip, Munir Pirmohamed
May 15, 2013·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Robert C BlockS Georas
Oct 6, 2010·The Pharmacogenomics Journal·T M Baye, R A Wilke
Aug 2, 2011·European Heart Journal·Jeffrey J W VerschurenJ Wouter Jukema
Oct 12, 2011·Journal of Veterinary Internal Medicine·J ThomasonA Mackin
Aug 7, 2012·Journal of Veterinary Internal Medicine·G NobleS L Raidal
Jun 10, 2010·Physiological Genomics·Jefferson C FrisbeeAlexandre C d'Audiffret
Sep 17, 2011·Circulation Research·Dan M RodenRussell A Wilke
Dec 12, 2012·Pharmacogenomics and Personalized Medicine·Paula Juliet Williams, Linda Morgan
Dec 19, 2009·Pharmacogenomics·Ana AlfirevicMunir Pirmohamed
Mar 15, 2014·Pharmacogenomics·Alfi YasminaVera H M Deneer
Sep 3, 2013·Pharmacology & Therapeutics·Christopher N Floyd, Albert Ferro
Dec 18, 2013·Medicina clínica·Hugo del Castillo-CarnevaliJosé Luis Zamorano Gómez
Dec 24, 2011·Thrombosis·Enma V Paez EspinosaFadi T Khasawneh
Dec 5, 2009·Advances in Hematology·Khaled MansourSamir Alam
Jul 1, 2009·Current Cardiology Reports·Sonny Dandona, Robert Roberts
Jun 26, 2013·Current Cardiology Reports·Adam S FischAlan R Shuldiner
Nov 18, 2008·Platelets·Giovanni de GaetanoChiara Cerletti
Oct 26, 2012·Critical Reviews in Clinical Laboratory Sciences·Matthew D Linden, Huyen A Tran
Jul 16, 2015·Expert Opinion on Drug Metabolism & Toxicology·Yao YangStuart A Scott
Mar 3, 2012·Annals of Medicine·Nadzeya KuzniatsovaGregory Y H Lip
Apr 4, 2015·International Journal of Cardiology·Payman Shahabi, Marie-Pierre Dubé
Oct 6, 2012·The Canadian Journal of Cardiology·Sonny Dandona, Robert Roberts
Feb 8, 2011·Pharmacology & Therapeutics·Richard Fitzgerald, Munir Pirmohamed
Jun 15, 2011·International Emergency Nursing·Sheila A Turris, Sheila Finamore
Sep 8, 2009·Progress in Cardiovascular Diseases·Udaya S TantryPaul A Gurbel
Jul 15, 2009·La Revue de médecine interne·J-L RenyP Fontana
Feb 14, 2009·International Journal of Cardiology·Marie LordkipanidzéChantal Pharand
Dec 9, 2008·Clinics in Laboratory Medicine·Mohammad Al-Ghoul, Roland Valdes
Jan 10, 2009·British Journal of Clinical Pharmacology·Y K LokeJ M Ritter
Jun 29, 2012·Clinical Cardiology·Jonathan Grinstein, Christopher P Cannon
Jan 4, 2012·Transplant International : Official Journal of the European Society for Organ Transplantation·Jonathan W ByrnesAdnan Bhutta
Aug 4, 2011·Journal of Thrombosis and Haemostasis : JTH·A D Johnson
Jul 3, 2013·Journal of Thrombosis and Haemostasis : JTH·M WürtzE L Grove
May 12, 2012·International Journal of Laboratory Hematology·A A TimurK Kottke-Marchant
Nov 9, 2010·International Journal of Laboratory Hematology·K M MusallamA T Taher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.